A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update

Veterinary Dermatology

Volumn 24, Issue 1, 2013, Pages

  Olivry, Thierry ^a   Bizikova, Petra ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; DOG; DOG DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

CANIS FAMILIARIS;

EID: 84872714127     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01088.x     Document Type: Article

References (46)

1. Halliwell R. Revised nomenclature for veterinary allergy. Vet Immunol Immunopathol 2006; 114: 2007-2008.
2. Linek M, Favrot C. Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners. Vet Dermatol 2010; 21: 456-462.
3. Noli C, Minafo G, Galzerano M. Quality of life of dogs with skin diseases and their owners. Part 1: development and validation of a questionnaire. Vet Dermatol 2011; 22: 335-343.
4. Olivry T, DeBoer DJ, Favrot C et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the international task force on canine atopic dermatitis. Vet Dermatol 2010; 21: 233-248.
5. Olivry T, Mueller RS, The International Task Force on Canine Atopic Dermatitis. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Vet Dermatol 2003; 14: 121-146.
6. Olivry T, Foster AP, Mueller RS et al. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol 2010; 21: 4-22.
7. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6: e1000100.
8. DeBoer DJ, Hillier A. The ACVD Task Force on Canine Atopic Dermatitis (XV): fundamental concepts in clinical diagnosis. Vet Immunol Immunopathol 2001; 81: 271-276.
9. Griffin CE, DeBoer DJ. The ACVD Task Force on Canine Atopic Dermatitis (XIV): clinical manifestations of canine atopic dermatitis. Vet Immunol Immunopathol 2001; 81: 255-269.
10. Willemse T. Atopic skin disease: a review and a reconsideration of diagnostic criteria. J Small Anim Pract 1986; 27: 771-778.
11. Prélaud P, Guaguère E, Alhaidari Z et al. Réévaluation des critères de diagnostic de la dermite atopique [reevaluation of diagnostic criteria of atopic dermatitis]. Rev Med Vet 1998; 149: 1057-1064.
12. Favrot C, Steffan J, Seewald W et al. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 2010; 21: 23-30.
13. Olivry T, Marsella R, Iwasaki T et al. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 2007; 18: 79-96.
14. Olivry T, Mueller R, Nuttall T et al. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis. Vet Dermatol 2008; 19: 115-119.
15. Hill PB, Lau P, Rybnicek J. Development of an owner-assessed scale to measure the severity of pruritus in dogs. Vet Dermatol 2007; 18: 301-308.
16. Rybnicek J, Lau-Gillard PJ, Harvey R et al. Further validation of a pruritus severity scale for use in dogs. Vet Dermatol 2009; 20: 115-122.
17. Moore RA, Gavaghan D, Tramèr MR et al. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998; 78: 209-216.
18. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997; 126: 712-720.
19. Marsella R, Messinger L, Zabel S et al. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis. Vet Dermatol 2010; 21: 50-57.
20. Pellicoro M, Marsella R, Ahrens K. Evaluation of the clinical and skin repair effects of dimethicone topical therapy in dogs with naturally occurring atopic dermatitis. Vet Dermatol 2011; 22: 291 (abstract).
21. Bryden SL, Burrows AK, Rème C et al. Efficacy of a 0.0584% hydrocortisone aceponate spray (Cortavance) for the management of pedal pruritus in atopic dogs: a pilot study. Vet Dermatol 2008; 19: 40 (abstract).
22. Gingerich DA, Woods CR. T-cell receptor (TCR) peptides - an immunotherapeutic approach for canine atopic dermatitis. In: American Academy of Veterinary Pharmacology and Therapeutics 17th Biannual Symposium. 2011; 6. Available at: http://www.aavpt.org/17thBiennial.shtml. Accessed June 18, 2012.
23. Sanchez N, Villanueva S, Torre C et al. Efficacy of a specific diet in the management of canine atopic dermatitis: a randomized, blinded, controlled clinical study. Vet Dermatol 2011; 22: 472 (abstract).
24. Lourenço-Martins AM, São-Braz B, Schmidt V et al. Long-term maintenance therapy of canine atopic dermatitis with a 0.0584% hydrocortisone aceponate spray (Cortavance) used on two consecutive days each week. Vet Dermatol 2012; 23: (Suppl 1): 39 (abstract).
25. Cadot P, Hensel P, Bensignor E et al. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase3 trial. Vet Dermatol 2011; 22: 554-564.
26. Nuttall T, Mueller R, Bensignor E et al. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial. Vet Dermatol 2009; 20: 191-198.
27. Schmidt V, McEwan N, Volk A et al. The glucocorticoid sparing efficacy of Phytopica™ in the management of canine atopic dermatitis: a randomised, double blind, placebo controlled trial. Vet Dermatol 2010; 21: 91-104.
28. Ahlstrom LA, Mason KV, Mills PC. Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial. J Vet Pharmacol Ther 2010; 33: 573-582.
29. Mueller RS, Specht L, Helmer M et al. The effect of nematode administration on canine atopic dermatitis. Vet Parasitol 2011; 181: 203-209.
30. Nuttall TJ, McEwan NA, Bensignor E et al. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis. Vet Dermatol 2012; 23: 4-10, e1-e2.
31. Noli C, Galzerano M, Toma S. Efficacia della somministrazione di olio di semi di ribes nero nella prevenzione del prurito e dei segni clinici della dermatite atopica stagionale (efficacy of the administration of blackcurrant seed oil in the prevention of pruritus and clinical signs of seasonal atopic dermatitis). Summa Anim Comp 2009; 9: 21-27.
32. Willemse T, Bardagi M, Carlotti DN et al. Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: a randomised, double blind, placebo-controlled study. Vet J 2009; 180: 337-342.
33. Singh SK, Dimri U, Saxena SK et al. Therapeutic management of canine atopic dermatitis by combination of pentoxifylline and PUFAs. J Vet Pharmacol Ther 2010; 33: 495-498.
34. Glos K, Linek M, Loewenstein C et al. The efficacy of commercially available veterinary diets recommended for dogs with atopic dermatitis. Vet Dermatol 2008; 19: 280-287.
35. Carlotti DN, Boulet M, Ducret J et al. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study. Vet Dermatol 2009; 20: 405-411.
36. Bensignor E, Morgan DM, Nuttall T. Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross-over study. Vet Dermatol 2008; 19: 156-162.
37. Plevnik A, Kobal S, Domanjko-Petric A et al. The efficacy of antihistamine fexofenadine versus methylprednisolone in the treatment of atopic dermatitis in dogs. Slovenian Vet Res - Slovenski Veterinarski Zbornik 2009; 46: 5-11.
38. Horvath-Ungerboeck C, Thoday KL, Shaw DJ et al. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. Vet Dermatol 2009; 20: 233-242.
39. Kovalik M, Taszkun I, Pomorski Z et al. Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells. Vet Rec 2011; 168: 537-542.
40. Yasukawa K, Saito S, Kubo T et al. Low-dose recombinant canine interferon-γ for treatment of canine atopic dermatitis: an open randomized comparative trial of two doses. Vet Dermatol 2010; 21: 42-49.
41. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926.
42. Steffan J, Parks C, Seewald W et al. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. J Am Vet Med Assoc 2005; 226: 1855-1863.
43. D'Agostino RB Sr, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Stat Med 2003; 22: 169-186.
44. Hill P, Rybnicek J, Lau-Gillard P. Correlation between pruritus score and grossly visible erythema in dogs. Vet Dermatol 2010; 21: 450-455.
45. Favrot C, Linek M, Mueller R et al. Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners. Vet Dermatol 2010; 21: 63-69.
46. Noli C, Colombo S, Cornegliani L et al. Quality of life of dogs with skin disease and of their owners. Part 2: administration of a questionnaire in various skin diseases and correlation to efficacy of therapy. Vet Dermatol 2011; 22: 344-351.